Long-term treatment of chronic schizophrenics with clopenthixol decanoate

Long-term treatment of chronic schizophrenics with clopenthixol decanoate

A study was carried out in 68 chronic schizophrenic out-patients to assess the therapeutic effectiveness and tolerance of long-term maintenance treatment with a depot preparation of clopenthixol decanoate. Patients received 200 mg to 600 mg doses by intramuscular injection every 2 to 3 weeks for a m...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1984), 1 vom: 22., Seite 53-6
1. Verfasser: Borsetti, G (VerfasserIn)
Weitere Verfasser: Rocco, P, Spilimbergo, P G, Giavedoni, A, Frangiamone, L, Beccaceci, A, Judice, A, Cisternino, M, Volterra, V
Format: Aufsatz
Sprache:English
Veröffentlicht: 1984
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Antipsychotic Agents Thioxanthenes clopenthixol decanoate 2HFX55AF4Y Clopenthixol 982-24-1